Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0015 Transporter Info
Gene Name ABCC4
Transporter Name Multidrug resistance-associated protein 4
Gene ID
10257
UniProt ID
O15439
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Probenecid

            3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Probenecid inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 2300 microM) [1]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 2

 Probenecid inhibits the transportation of Cholyltaurine by ABCC4 (IC50 = 100 microM) [2]

Affected Drug/Substrate

 Cholyltaurine Modulation Type Inhibition

Cell System

 Chinese hamster lung fibroblasts V79 cells (V79)-MRP4

  DT Modulation 3

 Probenecid inhibits the transportation of Cyclic guanosine monophosphate by ABCC4 (IC50 < 100 microM) [3]

Affected Drug/Substrate

 Cyclic guanosine monophosphate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP4

  Dipyridamole

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dipyridamole inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 2 microM) [1]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 2

 Dipyridamole inhibits the transportation of Cholyltaurine by ABCC4 (IC50 < 20 microM) [2]

Affected Drug/Substrate

 Cholyltaurine Modulation Type Inhibition

Cell System

 Chinese hamster lung fibroblasts V79 cells (V79)-MRP4

  Celecoxib

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Celecoxib inhibits the transportation of Methotrexate by ABCC4 (IC50 = 35 microM) [4]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 2

 Celecoxib inhibits the activity of ABCC4 [8]

  Diclofenac

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diclofenac inhibits the transportation of Methotrexate by ABCC4 (IC50 = 0.006 microM) [4]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 2

 Diclofenac inhibits the activity of ABCC4 [4] , [8]

  Indomethacin

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Indomethacin inhibits the transportation of Methotrexate by ABCC4 (IC50 = 6.1 microM) [4]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 2

 Indomethacin inhibits the activity of ABCC4 [10] , [11]

  Ketoprofen

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ketoprofen inhibits the transportation of Methotrexate by ABCC4 (IC50 = 11.9 microM) [4]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 2

 Ketoprofen inhibits the activity of ABCC4 [9]

  Sulindac

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulindac inhibits the transportation of Methotrexate by ABCC4 (IC50 = 2.11 microM) [4]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 2

 Sulindac inhibits the activity of ABCC4 [12] , [13]

  Telmisartan

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Telmisartan inhibits the transportation of Uric acid by ABCC4 (IC50 = 11 microM) [5]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP4

  DT Modulation 2

 Telmisartan inhibits the activity of ABCC4 [5]

  Cefmetazole

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefmetazole inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 [6]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP4

  DT Modulation 2

 Cefmetazole inhibits the activity of ABCC4 [9]

  Folic Acid

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Folic acid inhibits the transportation of Methotrexate by ABCC4 [7]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP4

  DT Modulation 2

 Folic acid inhibits the transportation of Sodium taurocholate by ABCC4 [2]

Affected Drug/Substrate

 Sodium taurocholate Modulation Type Inhibition

Cell System

 Chinese hamster lung fibroblasts V79 cells (V79)-MRP4

  Benzbromarone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzbromarone inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 150 microM) [1]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  Sildenafil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sildenafil inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 20 microM) [1]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  Sulfinpyrazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sulfinpyrazone inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 420 microM) [1]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  Candesartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Candesartan inhibits the transportation of Uric acid by ABCC4 (IC50 = 16 microM) [5]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP4

  Losartan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Losartan inhibits the transportation of Uric acid by ABCC4 (IC50 = 1.5 microM) [5]

Affected Drug/Substrate

 Uric acid Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP4

  Thioguanine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Thioguanine inhibits the transportation of Bimane-glutathione by ABCC4 [14]

Affected Drug/Substrate

 Bimane-glutathione Modulation Type Inhibition

Cell System

 Human hepatocellular carcinoma cell line (HepG2)-MRP4

  Quercetin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quercetin inhibits the transportation of Cyclic guanosine monophosphate by ABCC4 [15]

Affected Drug/Substrate

 Cyclic guanosine monophosphate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  Cefaclor

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefaclor inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 [6]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP4

  Cefadroxil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefadroxil inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 [6]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP4

  Cefamandole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefamandole inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 [6]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP4

  Cefoperazone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefoperazone inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 [6]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP4

  Cefoxitin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefoxitin inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 [6]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP4

  Ceftriaxone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ceftriaxone inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 [6]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP4

  Cefuroxime

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cefuroxime inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 [6]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP4

  Cephalexin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cephalexin inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 [6]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP4

  Cephradine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cephradine inhibits the transportation of Estradiol-17beta-glucuronide by ABCC4 [6]

Affected Drug/Substrate

 Estradiol-17beta-glucuronide Modulation Type Inhibition

Cell System

 Spodoptera frugiperda 21-MRP4

  Arsenic

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Arsenic increases the expression of ABCC4 [17]

Regulation Mechanism

 via enhancement of Nuclear respiratory factor 1 (NRF1) Transcription Factor Info

Cell System

 mouse bone marrow-derived mesenchymal stem cells

  Zidovudine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zidovudine increases the expression of ABCC4 [18]

  Arsenic Trioxide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Arsenic Trioxide inhibits the expression of ABCC4 [19]

  Vitamin D

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Vitamin D inhibits the expression of ABCC4 [19]

  Bortezomib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bortezomib inhibits the expression of ABCC4 [20]

  Aspirin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aspirin increases the expression of ABCC4 [21]

  Chenodeoxycholic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chenodeoxycholic acid inhibits the expression of ABCC4 [22]

  Methotrexate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methotrexate inhibits the expression of ABCC4 [23]

  Carbamazepine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Carbamazepine affects the expression of ABCC4 [24]

  Tolvaptan

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tolvaptan inhibits the activity of ABCC4 [25]

  Cisplatin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cisplatin inhibits the expression of ABCC4 [26]

  Valproic Acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valproic Acid inhibits the expression of ABCC4 [27]

  Mdv-3100

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Mdv-3100 inhibits the expression of ABCC4 [28]

  Doxorubicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Doxorubicin inhibits the expression of ABCC4 [29]

  Sunitinib

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sunitinib increases the expression of ABCC4 [30]

  Temozolomide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Temozolomide inhibits the expression of ABCC4 [31]

  Nefazodone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Nefazodone increases the expression of ABCC4 [32]

  Ivermectin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ivermectin inhibits the expression of ABCC4 [33]

  Estradiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Estradiol increases the expression of ABCC4 [35]

  Cyclosporine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyclosporine increases the expression of ABCC4 [36]

  Tretinoin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tretinoin inhibits the expression of ABCC4 [37]

  Etodolac

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Etodolac inhibits the activity of ABCC4 [4]

  Chlorothiazide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chlorothiazide inhibits the activity of ABCC4 [38]

  Furosemide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Furosemide inhibits the activity of ABCC4 [38]

  Acetaminophen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acetaminophen induces the activity of ABCC4 [39] , [40]

  Eetuximab

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Eetuximab induces the activity of ABCC4 [41]

  Flutamide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Flutamide induces the activity of ABCC4 [42]

Drug Marketed but not Approved by US FDA

  Rotenone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rotenone increases the expression of ABCC4 [34]

Drug in Phase 4 Trial

  Dihydrotestosterone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dihydrotestosterone induces the activity of ABCC4 [62]

Drug in Phase 3 Trial

  Oltipraz

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Oltipraz increases the expression of ABCC4 [43]

Drug in Phase 2 Trial

  Bisphenol A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Bisphenol A increases the expression of ABCC4 [45]

Regulation Mechanism

 via enhancement of Nuclear factor erythroid 2-related factor 2 (NFE2L2) Transcription Factor Info

Cell System

 Human fetal liver samples

  MS-275

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 MS-275 increases the expression of ABCC4 [54]

Drug in Phase 1 Trial

  Tetradecanoylphorbol Acetate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetradecanoylphorbol Acetate inhibits the expression of ABCC4 [19]

  TAK-875

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 TAK-875 inhibits the activity of ABCC4 [55]

  Adenosine Triphosphate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Adenosine Triphosphate affects the activity of ABCC4 [58]

  Sodium arsenite

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Sodium arsenite increases the expression of ABCC4 [59]

Drug in Preclinical Test

  (+)-JQ1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 (+)-JQ1 inhibits the expression of ABCC4 [48]

Discontinued Drug

  MK-571

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 MK-571 inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 10 microM) [1]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  DT Modulation 2

 MK-571 inhibits the transportation of Cholyltaurine by ABCC4 (IC50 = 2 microM) [2]

Affected Drug/Substrate

 Cholyltaurine Modulation Type Inhibition

Cell System

 Chinese hamster lung fibroblasts V79 cells (V79)-MRP4

  Trequinsin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Trequinsin inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 10 microM) [1]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  Zaprinast

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Zaprinast inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 250 microM) [1]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  Valspodar

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Valspodar inhibits the transportation of Methotrexate by ABCC4 [7]

Affected Drug/Substrate

 Methotrexate Modulation Type Inhibition

Cell System

 Spodoptera frugiperda (Sf9) cells-MRP4

Investigative Drug

  Dilazep

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Dilazep inhibits the transportation of 9-(2-Phosphonomethoxyethyl)adenine by ABCC4 (IC50 = 20 microM) [1]

Affected Drug/Substrate

 9-(2-Phosphonomethoxyethyl)adenine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  Metribolone

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Metribolone increases the expression of ABCC4 [46]

  Phenylmercuric Acetate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Phenylmercuric Acetate inhibits the expression of ABCC4 [53]

Patented Pharmaceutical Agent

  HSDB-595

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 HSDB-595 inhibits the expression of ABCC4 [49]

  GSK-J4

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 GSK-J4 inhibits the expression of ABCC4 [56]

Drug Withdrawn

  Rimonabant

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Rimonabant inhibits the transportation of Estradiol 17b-D-glucuronide by ABCC4 [16]

Affected Drug/Substrate

 Estradiol 17b-D-glucuronide Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

Natural Product

  Silymarin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Silymarin inhibits the transportation of Cyclic guanosine monophosphate by ABCC4 [15]

Affected Drug/Substrate

 Cyclic guanosine monophosphate Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  Plant polyphenols

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Plant polyphenols inhibits the transportation of [3H]-dinitrophenyl S-glutathione by ABCC4 [15]

Affected Drug/Substrate

 [3H]-dinitrophenyl S-glutathione Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MRP4

  6-bromoindirubin-3'-oxime

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 6-bromoindirubin-3'-oxime increases the expression of ABCC4 [47]

  Quercitrin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quercitrin inhibits the expression of ABCC4 [52]

  Deguelin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Deguelin increases the expression of ABCC4 [34]

  Tobacco Smoke Pollution

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tobacco Smoke Pollution increases the expression of ABCC4 [61]

Environmental toxicant

  Polychlorinated dibenzodioxin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Polychlorinated dibenzodioxin increases the expression of ABCC4 [44]

Regulation Mechanism

 via enhancement of Aryl hydrocarbon receptor (AHR) Transcription Factor Info

Cell System

 Human lung adenocarcinoma cells (H358)

  Tetrabromobisphenol A

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetrabromobisphenol A inhibits the activity of ABCC4 [51]

Mycotoxins

  Aflatoxin M1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Aflatoxin M1 inhibits the expression of ABCC4 [57]

Carcinogen

  Methylcholanthrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Methylcholanthrene increases the expression of ABCC4 [43]

Regulation Mechanism

 via enhancement of Aryl hydrocarbon receptor (AHR) Transcription Factor Info

Cell System

 Human hepatoblastoma cells (HepG2)

  Ethyl Methanesulfonate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ethyl Methanesulfonate inhibits the expression of ABCC4 [50]

  Benzo(a)pyrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzo(a)pyrene inhibits the expression of ABCC4 [60]

Health and Environmental Toxicant

  Perfluorooctane sulfonic acid

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Perfluorooctane sulfonic acid inhibits the activity of ABCC4 [51]
References
1 Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol Pharmacol. 2003 May;63(5):1094-103.
2 Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology. 2003 Aug;38(2):374-84.
3 The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol. 2002 Mar;13(3):595-603.
4 Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. J Pharmacol Exp Ther. 2007 Jan;320(1):229-35.
5 Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res. 2008 Mar;25(3):639-46.
6 Oral availability of cefadroxil depends on ABCC3 and ABCC4. Drug Metab Dispos. 2012 Mar;40(3):515-21.
7 Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res. 2002 Jun 1;62(11):3144-50.
8 Topotecan is a substrate for multidrug resistance associated protein 4. Curr Drug Metab. 2006 Jan;7(1):105-18.
9 Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins. J Pharmacol Exp Ther. 2010 Jun;333(3):912-9.
10 Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices. J Pharmacol Exp Ther. 2007 Sep;322(3):1162-70.
11 Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil. Biochem Pharmacol. 2010 Feb 1;79(3):455-62.
12 ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). J Pharmacol Exp Ther. 2008 Jan;324(1):86-94.
13 Fluo-cAMP is transported by multidrug resistance-associated protein isoform 4 in rat choroid plexus. J Neurochem. 2010 Oct;115(1):200-8.
14 Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane-glutathione. Int J Biochem Cell Biol. 2004 Feb;36(2):247-57.
15 Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J. 2005 Sep;272(18):4725-40.
16 Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4. Drug Metab Dispos. 2011 Jul;39(7):1294-302.
17 Long-isoform NRF1 protects against arsenic cytotoxicity in mouse bone marrow-derived mesenchymal stem cells by suppressing mitochondrial ROS and facilitating arsenic efflux. Toxicol Appl Pharmacol. 2020 Nov 15;407:115251.; 2020 Nov 15;407:115251.
18 ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages. Antivir Ther. 2004 Aug;9(4):519-28.
19 Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs. Int J Cancer. 2009 May 15;124(10):2303-11.
20 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
21 Prolonged use of aspirin alters human and rat intestinal cells and thereby limits the absorption of clopidogrel. Clin Pharmacol Ther. 2011 Oct;90(4):612-9.
22 Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. PLoS One. 2012;7(1):e30443.
23 Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. Arthritis Rheum. 2013 Nov;65(11):2791-802.
24 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFalpha-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59.
25 Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?. Toxicol Sci. 2016 Jan;149(1):237-50.
26 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
27 Stem Cell Transcriptome Responses and Corresponding Biomarkers That Indicate the Transition from Adaptive Responses to Cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
28 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
29 Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
30 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761.
31 Temozolomide induces activation of Wnt/beta-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278.
32 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172.
33 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975.
34 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615.
35 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
36 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
37 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423.
38 Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4. Br J Pharmacol. 2008 Dec;155(7):1066-75.
39 Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. Toxicol Sci. 2008 Aug;104(2):261-73.
40 Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. Am J Physiol Gastrointest Liver Physiol. 2008 Aug;295(2):G294-304.
41 Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters. Mol Pharm. 2017 Jun 5;14(6):2147-2157.
42 The antiandrogen flutamide is a novel aryl hydrocarbon receptor ligand that disrupts bile acid homeostasis in mice through induction of Abcc4. Biochem Pharmacol. 2016 Nov 1;119:93-104.
43 Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression. Am J Physiol Gastrointest Liver Physiol. 2010 Jul;299(1):G126-35.
44 Multidrug resistance protein (MRP) 4 attenuates benzo[a]pyrene-mediated DNA-adduct formation in human bronchoalveolar H358 cells. Toxicol Lett. 2012 Feb 25;209(1):58-66.; 2012 Feb 25;209(1):58-66.
45 Correlation between Conjugated Bisphenol A Concentrations and Efflux Transporter Expression in Human Fetal Livers. Drug Metab Dispos. 2016 Jul;44(7):1061-5.; 2016 Jul;44(7):1061-5.
46 Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell. 2006 Oct;10(4):321-30.
47 Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. J Neurochem. 2008 Aug;106(4):1855-65.
48 BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011 Sep 16;146(6):904-17.
49 Diallyl sulfide, diallyl disulfide and diallyl trisulfide affect drug resistant gene expression in colo 205 human colon cancer cells in vitro and in vivo. Phytomedicine. 2012 May 15;19(7):625-30.
50 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
51 Endocrine disruptors differentially target ATP-binding cassette transporters in the blood-testis barrier and affect Leydig cell testosterone secretion in vitro. Toxicol Sci. 2013 Dec;136(2):382-91.
52 Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer. Arch Med Res. 2014 Aug;45(6):445-54.
53 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
54 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
55 Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury. Toxicol Sci. 2018 Jun 1;163(2):374-384.
56 Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. J Biol Chem. 2018 Feb 16;293(7):2422-2437.
57 Transcriptome analysis revealed that aflatoxin M1 could cause cell cycle arrest in differentiated Caco-2 cells. Toxicol In Vitro. 2019 Sep;59:35-43.
58 Human multidrug resistance protein 4 (MRP4) is a cellular efflux transporter for paracetamol glutathione and cysteine conjugates. Arch Toxicol. 2020 Sep;94(9):3027-3032.
59 Capturing time-dependent activation of genes and stress-response pathways using transcriptomics in iPSC-derived renal proximal tubule cells. Cell Biol Toxicol. 2022 Dec 31.
60 Genome-Wide Transcriptional and Functional Analysis of Human T Lymphocytes Treated with Benzo[ alpha]pyrene. Int J Mol Sci. 2018 Nov 17;19(11):3626.
61 Assessment of a 72-hour repeated exposure to Swedish snus extract and total particulate matter from 3R4F cigarette smoke on gingival organotypic cultures. Food Chem Toxicol. 2019 Mar;125:252-270.
62 Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells. Prostate Cancer Prostatic Dis. 2007;10(1):39-45.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.